Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Magenta Therapeutics, Inc. (MGTA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/15/2023 |
SC 13G
| CITADEL ADVISORS LLC reports a 6.7% stake in Magenta Therapeutics, Inc. |
| 02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 09/26/2022 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 6.1% stake in MAGENTA THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G
| Aquilo Capital Management, LLC reports a 5.4% stake in Magenta Therapeutics, Inc. |
| 05/14/2021 |
SC 13G
| Deep Track Capital, LP reports a 7.1% stake in Magenta Therapeutics, Inc. |
| 02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 06/10/2019 |
SC 13G
| GILDER GAGNON HOWE & CO LLC reports a 10.6% stake in Magenta Therapeutics, Inc. |
| 02/13/2019 |
SC 13G
| Atlas Venture Fund X, L.P. reports a 14.6% stake in Magenta Therapeutics, Inc. |
| 02/13/2019 |
SC 13G
| Third Rock Ventures GP IV, L.P. reports a 24.2% stake in Magenta Therapeutics, Inc. |
| 02/13/2019 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/11/2019 |
SC 13G
| GV 2016, L.P. reports a 10.1% stake in Magenta Therapeutics, Inc. |
| 07/02/2018 |
SC 13G
| Casdin Capital, LLC reports a 5.9% stake in Magenta Therapeutics, Inc. |
|
|